Enter global pharmaceutical giants. US-based Eli Lilly and Novo Nordisk have both launched GLP-1-based treatments in India in ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

But the big thing is that the HRA providers and the insurers they work with are intensely interested in employers and ...

There are a few potential risks to keep in mind with rice water, including some food safety concerns.

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...

GLP-1 drugs, which have seen widespread success, have been linked to a number of cases of pancreatitis in the UK, which have ...

A handful of New York City restaurants have been putting smaller portion sizes on their menus amid the rise of weight-loss ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...